Cosan528 is primarily utilized in the field of boron neutron capture therapy (BNCT), a targeted cancer treatment. It serves as a boron carrier, delivering boron-10 isotopes to cancer cells. When exposed to neutron radiation, the boron-10 atoms undergo a nuclear reaction, releasing high-energy particles that destroy the cancer cells while minimizing damage to surrounding healthy tissue. This makes Cosan528 a promising agent for treating certain types of tumors, particularly those that are difficult to address with conventional therapies. Its application is currently under research and development, with potential for use in clinical oncology.